Chest CT Measures of Muscle and Adipose Tissue in COPD: Gender-based Differences in Content and in Relationships with Blood Biomarkers

Academic Radiology

Volumn 21, Issue 10, 2014, Pages 1255-1261

  Diaz, Alejandro A ^a   Zhou, Linfu ^a   Young, Tom P ^a   McDonald, Merry Lynn ^a   Harmouche, Rola ^a   Ross, James C ^a   San Jose Estepar, Raul ^a   Wouters, Emiel F M ^b   Coxson, Harvey O ^c   MacNee, William ^d   Rennard, Stephen ^e   Maltais, François ^f   Kinney, Gregory L ^g   Hokanson, John E ^g   Washko, George R ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

^f LAVAL UNIVERSITY   (Canada)

^g Food Science and Human Nutrition   (United States)

Author keywords

Adipose subcutaneous tissue; Biomarkers; COPD; CRP; CT; Fibrinogen; IL 6; Pectoralis muscle

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; INTERLEUKIN 6; BIOLOGICAL MARKER;

ADULT; AGED; ANATOMICAL VARIATION; AORTA ARCH; ARTICLE; BODY COMPOSITION; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; FAT MASS; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PECTORALIS MAJOR MUSCLE; SEX DIFFERENCE; SUBCUTANEOUS FAT; TISSUE SLICE; BLOOD; BREATHING MUSCLE; CLINICAL TRIAL; INTERNATIONAL COOPERATION; LONGITUDINAL STUDY; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; OBESITY; PATHOPHYSIOLOGY; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RADIOGRAPHY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SEX RATIO; SEXUAL DEVELOPMENT; STATISTICS AND NUMERICAL DATA; THORAX RADIOGRAPHY;

ADIPOSITY; ADULT; AGED; BIOMARKERS; C-REACTIVE PROTEIN; FEMALE; FIBRINOGEN; HUMANS; INTERNATIONALITY; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RADIOGRAPHY, THORACIC; REPRODUCIBILITY OF RESULTS; RESPIRATORY MUSCLES; SENSITIVITY AND SPECIFICITY; SEX CHARACTERISTICS; SEX DISTRIBUTION; SUBCUTANEOUS FAT; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84908233510     PISSN: 10766332     EISSN: 18784046     Source Type: Journal    
DOI: 10.1016/j.acra.2014.05.013     Document Type: Article

References (28)

1. Ford E.S., Mannino D.M., Wheaton A.G., et al. Trends in the prevalence of obstructive and restrictive lung function among adults in the United States: findings from the National Health and Nutrition Examination surveys from 1988-1994 to 2007-2010. Chest 2013, 143:1395-1406.
2. Sava F., Laviolette L., Bernard S., et al. The impact of obesity on walking and cycling performance and response to pulmonary rehabilitation in COPD. BMC Pulm Med 2010, 10:55.
3. Rutten E.P., Calverley P.M., Casaburi R., et al. Changes in body composition in patients with chronic obstructive Pulmonary disease: do theyinfluence patient-related outcomes?. Ann Nutr Metab 2013, 63:239-247.
4. Schols A.M., Broekhuizen R., Weling-Scheepers C.A., et al. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 2005, 82:53-59.
5. Kim S.B., Kang Y.A., Jung J.Y., et al. Body mass index and fat free mass index in obstructive lung disease in Korea. Int J Tuberc Lung Dis 2014, 18:102-108.
6. Hronek M., Kovarik M., Aimova P., et al. Skinfold anthropometry-the accurate method for fat free mass measurement in COPD. COPD 2013, 10:597-603.
7. Marquis K., Debigare R., Lacasse Y., et al. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002, 166:809-813.
8. Romme E.A., Murchison J.T., Edwards L.D., et al. CT-measured bone attenuation in patients with chronic obstructive pulmonary disease: relation toclinical features and outcomes. J Bone Miner Res 2013, 28:1369-1377.
9. Diaz A.A., Morales A., Diaz J.C., et al. CT and physiologic determinants of dyspnea and exercise capacity during the six-minute walk test in mild COPD. Respir Med 2013, 107:570-579.
10. McDonald M.L., Diaz A.A., Ross J.C., et al. Quantitative computed tomography measures of pectoralis muscle area and disease severity in chronic obstructive pulmonary disease. A cross-sectional study. Ann Am Thorac Soc 2014, 11:326-334.
11. van den Borst B., Gosker H.R., Wesseling G., et al. Low-grade adipose tissue inflammation in patients with mild-to-moderate chronic obstructive pulmonary disease. Am J Clin Nutr 2011, 94:1504-1512.
12. Breyer M.K., Rutten E.P., Vernooy J.H., et al. Gender differences in theadipose secretome system in chronic obstructive pulmonary disease (COPD): a pivotal role of leptin. Respir Med 2011, 105:1046-1053.
13. Ahonen T.M., Kautiainen H.J., Keinanen-Kiukaanniemi S.M., et al. Gender difference among smoking, adiponectin, and high-sensitivity C-reactive protein. Am J Prev Med 2008, 35:598-601.
14. Vestbo J., Anderson W., Coxson H.O., et al. Evaluation of COPD longitudinally to identify predictive surrogate end-points (ECLIPSE). Eur Respir J 2008, 31:869-873.
15. Steiner M.C., Barton R.L., Singh S.J., et al. Bedside methods versus dual energy X-ray absorptiometry for body composition measurement in COPD. Eur Respir J 2002, 19:626-631.
16. Vestbo J., Edwards L.D., Scanlon P.D., et al. Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med 2011, 365:1184-1192.
17. Lin L.I. A concordance correlation coefficient to evaluate reproducibility. Biometrics 1989, 45:255-268.
18. Bland J.M., Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986, 1:307-310.
19. Mannino D.M., Ford E.S., Redd S.C. Obstructive and restrictive lungdisease and markers of inflammation: data from the Third National Health and Nutrition Examination. Am J Med 2003, 114:758-762.
20. Duvoix A., Dickens J., Haq I., et al. Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease. Thorax 2013, 68:670-676.
21. Nillawar A.N., Joshi K.B., Patil S.B., et al. Evaluation of HS-CRP and lipid profile in COPD. J Clin Diagn Res 2013, 7:801-803.
22. Ferrari R., Tanni S.E., Caram L.M., et al. Three-year follow-up of interleukin 6 and C-reactive protein in chronic obstructive pulmonary disease. Respir Res 2013, 14:24.
23. Thomsen M., Ingebrigtsen T.S., Marott J.L., et al. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease. JAMA 2013, 309:2353-2361.
24. Man S.F., Connett J.E., Anthonisen N.R., et al. C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax 2006, 61:849-853.
25. Dahl M., Vestbo J., Lange P., et al. C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007, 175:250-255.
26. Pou K.M., Massaro J.M., Hoffmann U., et al. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation 2007, 116:1234-1241.
27. Seymour J.M., Ward K., Sidhu P.S., et al. Ultrasound measurement ofrectus femoris cross-sectional area and the relationship with quadriceps strength in COPD. Thorax 2009, 64:418-423.
28. Maltais F. Body composition in COPD: looking beyond BMI [Editorial]. Int J Tuberc Lung Dis 2014, 18:3-4.